Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were highly prized acquisition targets in 2018, a new analysis shows. . . . → Read More: Venture Funds, Mergers in A.I. Up Sharply in 2018
|
|||||
|
|
A company developing treatments for inherited eye diseases that replace malfunctioning with healthy genes is being acquired by biotechnology company Biogen. . . . → Read More: Biogen Acquires Gene Therapy Company in $800M Deal  Comments are closed  Finance  biomedical, biotechnology, clinical trials, entrepreneurs, equity, genomics, investment, life sciences, merger, pharmaceuticals, U.K., university 
Spark Therapeutics, a biotechnology company that pioneered gene therapies, is being acquired by drug maker Roche Group in a deal valued at $4.3 billion. . . . → Read More: Gene Therapy Company Acquired in $4.3B Deal One comment - (Comments are closed) Finance biomedical, biotechnology, equity, FDA, genomics, investment, life sciences, merger, pharmaceuticals, university 
A new biotechnology enterprise developing personalized treatments that harness the immune system to treat cancer is raising $10.5 million in its first venture funding round. . . . → Read More: Start-Up Raises $10.5M for Precision Immunotherapies One comment - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, cancer, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, preclinical, venture capital 
Research done at Massachusetts Institute of Technology in 2018 led to creation of 32 new start-up enterprises as well as hundreds of licenses and patents. . . . → Read More: MIT Spins-Off 32 Start-Ups in 2018 Comments are closed Intellectual property, Joint ventures/collaborations economics, energy, entrepreneurs, investment, licensing, life sciences, patent, physical sciences, university 
A new company formed to commercialize research that aims to prevent cancer from spreading or recurring is raising $60.75 million in its first venture financing. . . . → Read More: Company to Stop Cancer Spread, Relapse Raises $60.8M 2 comments - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, cancer, entrepreneurs, equity, investment, licensing, life sciences, medical device, pharmaceuticals, university, venture capital 
A new venture capital fund is being formed to finance start-up companies developing technologies that aim to extend healthy human life spans. . . . → Read More: Venture Fund Formed to Back Longevity Research One comment - (Comments are closed) Finance biomedical, biotechnology, engineering, entrepreneurs, equity, investment, life sciences, mathematics, medical device, pharmaceuticals, physical sciences, software, U.K., venture capital 
An ingestible gel capsule is shown in tests with animals to expand and reside in the stomach for as long as a month for delivering drugs or monitoring bodily functions. . . . → Read More: Expanding Gel Pill Designed for Long-Term Diagnostics One comment - (Comments are closed) New products Asia, biomedical, China, engineering, entrepreneurs, equity, investment, life sciences, materials science, medical device, patent, pharmaceuticals, physical sciences, university, venture capital 
Yesterday, we reported on 2018 being a banner year for venture capital, but the New York Times says a movement of entrepreneurs is looking for other ways to raise money. . . . → Read More: Start-Ups Saying No Thanks to Venture Capital 
Venture funding last year totaled $99.5 billion, the largest annual outlay since 2000. . . . → Read More: Infographic – Venture Finance Reaching Dot-Com Levels |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||